Showing 100,781 - 100,800 results of 103,386 for search '(( 10 nm decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.47s Refine Results
  1. 100781
  2. 100782
  3. 100783

    Effect of TSC1 deficiency on B cell development in the spleen. by Xinxin Ci (168133)

    Published 2015
    “…Data shown represent or are calculated from at least five experiments with a total of ten mice in each group. …”
  4. 100784
  5. 100785

    2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells by Kuan-Lin Kuo (177505)

    Published 2013
    “…The synergistic antitumor effect with As<sub>2</sub>O<sub>3</sub> provides a novel implication in clinical treatment of UC.…”
  6. 100786
  7. 100787
  8. 100788

    Table1_Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel in vivo and in vitro.docx by Haifang Chen (8123441)

    Published 2022
    “…The anticancer mechanism of the PTX-JG combination in A549/PTX cells was elucidated based on cell proliferation, annexin V-FITC apoptosis assay, and western blotting. …”
  9. 100789
  10. 100790

    Factors associated with desired fertility among HIV-positive women and men attending two urban clinics in Lilongwe, Malawi by Jamie W. Krashin (5391131)

    Published 2018
    “…For women, believing that pregnancy was unhealthy was associated with decreased fertility desire. Fifty-five percent of women and 69% of men who did not want children in the future reported using contraception at last intercourse. …”
  11. 100791

    Datasheet1_Further delineation of EBF3-related syndromic neurodevelopmental disorder in twelve Chinese patients.docx by Jitao Zhu (14711959)

    Published 2023
    “…<p>Neurodevelopmental disorders (NDDs) have heterogeneity in both clinical characteristics and genetic factors. EBF3 is a recently discovered gene associated with a syndromic form of NDDs characterized by hypotonia, ataxia and facial features. …”
  12. 100792

    Data_Sheet_1.DOCX by Yoosoo Yang (2572699)

    Published 2018
    “…<p>Vesicle-associated V-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins and target membrane-associated T-SNAREs (syntaxin 4 and SNAP-23) assemble into a core trans-SNARE complex that mediates membrane fusion during mast cell degranulation. …”
  13. 100793

    Comparative Site-Specific <i>O</i>‑Glycosylation Analysis of the Milk Fat Globule Membrane Proteome in Donkey Colostrum and Mature Milk by Boyuan Guan (17743654)

    Published 2024
    “…As lactation progressed, the number of site-specific <i>O</i>-glycans from three glycoproteins significantly increased, whereas that of 11 site-specific <i>O</i>-glycans from five glycoproteins significantly decreased. Furthermore, donkey MFGM <i>O</i>-glycoproteins with core-1 and core-2 core structures and Lewis and sialylated branch structures may be involved in regulating apoptosis. …”
  14. 100794

    Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission by Geneviève Boily-Larouche (152000)

    Published 2012
    “…DC-SIGN promoter (p-336C and p-201A) and exon 4 (198Q and 242V) variants were all significantly associated with increased risk of intrauterine (IU) HIV-1 infection. …”
  15. 100795

    Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota by Mengzhen Han (12503834)

    Published 2024
    “…Specifically, it significantly increased the abundance of Muribaculaceae, Lactobacillus, Bacteroides, and Enterorhabdus, while decreasing the abundance of Escherichia-Shigella. Furthermore, our nontargeted metabolomics analysis illustrated that B. bifidum M1-3 treatment had a regulatory effect on various metabolic pathways, including tyrosine metabolism, lysine degradation, and tryptophan metabolism. …”
  16. 100796
  17. 100797
  18. 100798
  19. 100799

    Experiment 3. by Ottavia Benedicenti (9100619)

    Published 2024
    “…Trial G used 3 mL of DNA/RNA Shield™ with a flow rate setting of 3.8 to 4.0 L/min (vacuum pump).…”
  20. 100800

    DataSheet1_I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway.pdf by Yafeng Liu (192716)

    Published 2022
    “…In many cardiovascular diseases, I-κB kinase-ε (IKKε) has been recognized as a pro-inflammatory molecule. In this study, wild-type mice (WT, n = 14) and IKKε knockout mice (IKKε-KO, n = 14) were intraperitoneally injected with a cumulative dose of 25 mg/kg with Dox or Saline five times in 30 days. …”